期刊文献+

应用ROC曲线分析cTnT和CK-MB对急性心肌梗死的诊断价值 被引量:2

Assessment of receiver operator character curves on diagnostic value of cTnT and CK-MB in acute moycardial infaction
下载PDF
导出
摘要 目的应用ROC曲线分析心肌肌钙蛋白T(cTnT)和CK-MB对急性心肌梗死的诊断价值。方法检测心梗组、疑似心梗组和健康对照组的血清cTnT、CK-MB水平,所得数据进行t检验和ROC统计分析。结果心梗组、疑似心梗组和健康对照组的血清cTnT、CK-MB水平两两之间有显著差异。cTnT的ROC曲线下面积为0.918,CK-MB的ROC曲线下面积为0.805,cTnT诊断价值高于CK-MB。结论血清cTnT是诊断急性心肌梗死灵敏而特异的诊断指标,其诊断性能明显优于CK-MB,CK-MB可作为诊断急性心肌梗死的辅助诊断指标。 Objective To analyze the cardiac troponin T and CK-MB in the diagnosis value of acute myocardial in- faretion(AMI} by receiver operating characteristic (ROC) curves. Methods cTnT and CK-MB was detected in AMI pa- tients, suspected AMI patients and control group. Results There was significant difference in eTnT and CK-MB level in AMI patients, suspected AMI patients and control group. Area under ROC eurve of cTnT was 0. 918, and area under ROC curve of CK-MB was 0. 805. cTnT has more diagnostic value than CK-MB. Conclusion The eTnT is eonfirmed to be the sensitive and specific for detection of AMI, and the eTnT get the better of the CK-MB in the diagnostic peeuliar performanee, CK-MB is confirmed to be the assistant for detection of acute myocardial infarction.
出处 《西部医学》 2009年第10期1796-1797,共2页 Medical Journal of West China
关键词 急性心肌梗死 心肌肌钙蛋白T CK—MB ROC曲线 Acute myocardial infarction Cardiac troponin T CK-MB Receiver operating eharaeteristic curves
  • 相关文献

参考文献3

二级参考文献58

  • 1王前,郑磊,曾方银.超敏C-反应蛋白的研究现状及临床应用[J].中华检验医学杂志,2004,27(8):542-544. 被引量:193
  • 2潘柏申.心脏标志物的临床应用[J].中华检验医学杂志,2005,28(1):124-126. 被引量:62
  • 3[1]Wu A H B. Biochemical markers of cardiac damage: from traditional enzymes to cardiac-specific proteins[J]. Scand J Clin Lab Invest,1999,59(Suppl 230): 74-82.
  • 4[2]Panteghni M, Apple F S, Christenson R H, et al. Proposal from IFCC committee on Standadization of Markers of Cardiac Damage (C-SMCD): recommendation on use of biochemical markers of cardiac damage in acute coronary syndromes [J]. Scand J Clin Lab Invest, 1999,59(Suppl 230): 103-112.
  • 5[3]Wu A H,Apple F S ,Gibler W B, et al. National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery disease[J]. Clin Chem,1999,45: 1104-1121.
  • 6[4]Alpert J S, Thygesen K, Antman E, et al. Myocardial infarction redefined:a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction[J]. J Am Coll Cardiol, 2000,36: 959-969.
  • 7[5]Giri S,Waters D D,Wu A H B. Pathophysiology of acute coronary syndromes In: Card iac markers. Ed. Wu A H B. New Jersey:Humana Press Inc, 1998.21-44.
  • 8[6]Winter R J, Fischer J, Bholasingh R, et al. C-reactive protein and cardiac troponin T in risk stratification:differences in optimal timing of tests early after the onset of chest pain[J]. Clin Chem,2000,46:1597-1603.
  • 9[7]Koenig W, Sund M, Frohlich M, et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary, heart disease in initial healthy middle-aged men: results from the MONICA Augsburg Cohort Study, 1984 to 1992 [J]. Circulation, 1999, 99:237-242.
  • 10[8]Zimmerman J, Fromm R, Meyer D, et al. Diagnostic marker cooperative study for the diagnosis of myocardial infarction [J].Circulation, 1999,99: 1671-1677.

共引文献152

同被引文献26

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部